These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31490328)

  • 1. Sexually dimorphic therapeutic response in bortezomib-induced neuropathic pain reveals altered pain physiology in female rodents.
    Stockstill K; Wahlman C; Braden K; Chen Z; Yosten GL; Tosh DK; Jacobson KA; Doyle TM; Samson WK; Salvemini D
    Pain; 2020 Jan; 161(1):177-184. PubMed ID: 31490328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1.
    Janes K; Little JW; Li C; Bryant L; Chen C; Chen Z; Kamocki K; Doyle T; Snider A; Esposito E; Cuzzocrea S; Bieberich E; Obeid L; Petrache I; Nicol G; Neumann WL; Salvemini D
    J Biol Chem; 2014 Jul; 289(30):21082-97. PubMed ID: 24876379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain.
    Stockstill K; Doyle TM; Yan X; Chen Z; Janes K; Little JW; Braden K; Lauro F; Giancotti LA; Harada CM; Yadav R; Xiao WH; Lionberger JM; Neumann WL; Bennett GJ; Weng HR; Spiegel S; Salvemini D
    J Exp Med; 2018 May; 215(5):1301-1313. PubMed ID: 29703731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine-1-phosphate receptor subtype 1 activation in the central nervous system contributes to morphine withdrawal in rodents.
    Doyle TM; Hutchinson MR; Braden K; Janes K; Staikopoulos V; Chen Z; Neumann WL; Spiegel S; Salvemini D
    J Neuroinflammation; 2020 Oct; 17(1):314. PubMed ID: 33092620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Morphine-Induced Changes in Signaling at the A
    Doyle TM; Largent-Milnes TM; Chen Z; Staikopoulos V; Esposito E; Dalgarno R; Fan C; Tosh DK; Cuzzocrea S; Jacobson KA; Trang T; Hutchinson MR; Bennett GJ; Vanderah TW; Salvemini D
    J Pharmacol Exp Ther; 2020 Aug; 374(2):331-341. PubMed ID: 32434943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain.
    Chen Z; Doyle TM; Luongo L; Largent-Milnes TM; Giancotti LA; Kolar G; Squillace S; Boccella S; Walker JK; Pendleton A; Spiegel S; Neumann WL; Vanderah TW; Salvemini D
    Proc Natl Acad Sci U S A; 2019 May; 116(21):10557-10562. PubMed ID: 31068460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine-1-phosphate signaling: A novel target for simultaneous adjuvant treatment of triple negative breast cancer and chemotherapy-induced neuropathic pain.
    Singh SK; Spiegel S
    Adv Biol Regul; 2020 Jan; 75():100670. PubMed ID: 31708456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of sphingosine-1-phosphate receptor subtype 1 in the central nervous system contributes to morphine-induced hyperalgesia and antinociceptive tolerance in rodents.
    Doyle TM; Janes K; Chen Z; Grace PM; Esposito E; Cuzzocrea S; Largent-Milnes TM; Neumann WL; Watkins LR; Spiegel S; Vanderah TW; Salvemini D
    Pain; 2020 Sep; 161(9):2107-2118. PubMed ID: 32301840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy.
    Janes K; Wahlman C; Little JW; Doyle T; Tosh DK; Jacobson KA; Salvemini D
    Brain Behav Immun; 2015 Feb; 44():91-9. PubMed ID: 25220279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn.
    Doolen S; Iannitti T; Donahue RR; Shaw BC; Grachen CM; Taylor BK
    Pain; 2018 Feb; 159(2):224-238. PubMed ID: 29140922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-induced pain is promoted by enhanced spinal adenosine kinase levels through astrocyte-dependent mechanisms.
    Wahlman C; Doyle TM; Little JW; Luongo L; Janes K; Chen Z; Esposito E; Tosh DK; Cuzzocrea S; Jacobson KA; Salvemini D
    Pain; 2018 Jun; 159(6):1025-1034. PubMed ID: 29419652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Adenosine Kinase in Sphingosine-1-Phosphate Receptor 1-Induced Mechano-Hypersensitivities.
    Lauro F; Giancotti LA; Kolar G; Harada CM; Harmon TA; Garrett TJ; Salvemini D
    Cell Mol Neurobiol; 2022 Nov; 42(8):2909-2918. PubMed ID: 34773542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of opioid-induced rewarding effects under oxaliplatin- and Paclitaxel-induced neuropathy in rats.
    Mori T; Kanbara T; Harumiya M; Iwase Y; Masumoto A; Komiya S; Nakamura A; Shibasaki M; Kanemasa T; Sakaguchi G; Suzuki T
    J Pharmacol Sci; 2014; 126(1):47-55. PubMed ID: 25141998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTY720/Fingolimod mitigates paclitaxel-induced Sparcl1-driven neuropathic pain and breast cancer progression.
    Singh SK; Weigel C; Brown RDR; Green CD; Tuck C; Salvemini D; Spiegel S
    FASEB J; 2024 Aug; 38(15):e23872. PubMed ID: 39126272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states.
    Little JW; Ford A; Symons-Liguori AM; Chen Z; Janes K; Doyle T; Xie J; Luongo L; Tosh DK; Maione S; Bannister K; Dickenson AH; Vanderah TW; Porreca F; Jacobson KA; Salvemini D
    Brain; 2015 Jan; 138(Pt 1):28-35. PubMed ID: 25414036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways.
    Janes K; Esposito E; Doyle T; Cuzzocrea S; Tosh DK; Jacobson KA; Salvemini D
    Pain; 2014 Dec; 155(12):2560-2567. PubMed ID: 25242567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaining on Pain.
    Emery EC; Wood JN
    N Engl J Med; 2018 Aug; 379(5):485-487. PubMed ID: 30067934
    [No Abstract]   [Full Text] [Related]  

  • 18. Participation of transient receptor potential vanilloid 1 in the analgesic effect of duloxetine for paclitaxel induced peripheral neuropathic pain.
    Wang J; Zhou F; Zhang S; Mao M; Feng S; Wang X
    Neurosci Lett; 2022 Mar; 773():136512. PubMed ID: 35149198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic Effects of Sokeikakketsuto on Chemotherapy-Induced Mechanical Allodynia and Cold Hyperalgesia in Rats.
    Nakamura H; Kawashiri T; Kobayashi D; Uchida M; Egashira N; Shimazoe T
    Biol Pharm Bull; 2021; 44(2):271-274. PubMed ID: 33518680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presynaptic mGluR5 receptor controls glutamatergic input through protein kinase C-NMDA receptors in paclitaxel-induced neuropathic pain.
    Xie JD; Chen SR; Pan HL
    J Biol Chem; 2017 Dec; 292(50):20644-20654. PubMed ID: 29074619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.